|
Aug 14
|
Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services
|
|
Aug 13
|
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
|
|
Aug 6
|
Evotec SE to announce first half-year results 2025 on 13 August 2025
|
|
Aug 4
|
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
|
|
Jul 22
|
Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release
|
|
Jul 21
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Anticipated Earnings
|
|
Jul 21
|
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
|
|
Jul 21
|
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
|
|
Jun 29
|
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery
|
|
Jun 26
|
Basic Materials Roundup: Market Talk
|
|
May 7
|
Evotec SE (EVO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Embracing ...
|
|
May 7
|
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
|
|
May 6
|
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
|
|
Apr 10
|
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
|